<?xml version="1.0" encoding="UTF-8" ?>
<document
    xmlns="http://maven.apache.org/XDOC/2.0"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xsi:schemaLocation="http://maven.apache.org/XDOC/2.0
    http://maven.apache.org/xsd/xdoc-2.0.xsd">
    <properties>
        <title>Home Page</title>
        <author email="michael.schnieders@gmail.com">
            Michael Schnieders
        </author>
    </properties>
    <body>
        <section name="Introduction">
            <p>Force Field X is a group of open source (GPL v. 3), platform independent
               (Java Runtime Environment) modules for molecular biophysics.
               Key methods include:
            </p>
            <ul>
                <li>Polarizable AMOEBA force fields</li>
                <li>Particle-mesh Ewald electrostatics</li>
                <li>Generalized Kirkwood continuum electrostatics</li>
                <li>X-ray and neutron crystallography refinement</li>
                <li>Real space refinement for CryoEM</li>
                <li>Methods for structure based drug design</li>
            </ul>
            <subsection name="Ewald X-Ray Crystallography Refinement">
                <p>In collaboration with scientists at Vertex Pharmcueticals, we are using the
                polarizable AMOEBA force field evaluated using Ewald summation to re-refine
                protein-drug structures in the context of the original diffraction data (ie. using
                an X-ray likelihood target) in order to provide the most precise atomic
                resolution models possible.
                </p>
                <p>The Ewald refinements exhibit:</p>
                <ol>
                    <li>Improved agreement with the data (lower Rfree values)</li>
                    <li>Fewer van der Waals clashes</li>
                    <li>A greater percentage of favorable backbone confirmations</li>
                    <li>Overall improvement of MolProbity score</li>
                    <li>Refinement of the hydrogen-bonding network within the binding pocket</li>
                </ol>
                <table>
                    <tbody>
                        <tr>
                            <td>
                                <font color="blue">Original (1YI4, No Electrostatics)</font>
                            </td>
                            <td>
                                <font color="blue">Ewald Refinement of the Binding Pocket</font>
                            </td>
                        </tr>
                        <tr>
                            <td bgcolor="white">
                                <p align="center">
                                    <img src="images/actsite_init_small.png" alt="No Electrostatics" />
                                </p>
                            </td>
                            <td bgcolor="white">
                                <p align="left">
                                    <img src="images/actsite_ffx_small.png" alt="AMOEBA PME Electrostatics" />
                                </p>
                            </td>
                        </tr>
                    </tbody>
                </table>
                <table>
                    <thead>
                        <tr>
                            <th>Model</th>
                            <th>R</th>
                            <th>Rfree</th>
                            <th>Clash Score and Percentile</th>
                            <th>Poor Rotamer</th>
                            <th>Ramachandram Favored</th>
                            <th>MolProbity Score and Percentile</th>
                            <th>Resolution (A)</th>
                            <th>Structure</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td>
                                <font color="blue">Original Refinements</font>
                            </td>
                        </tr>
                        <tr>
                            <td>PIM-1 Bound to Adenosine</td>
                            <td>20.22</td>
                            <td>23.49</td>
                            <td>24.91 / 46th</td>
                            <td> 7.56%</td>
                            <td>93.92%</td>
                            <td> 2.96 / 33rd</td>
                            <td>2.4</td>
                            <td>
                                <a href="http://www.rcsb.org/pdb/explore/explore.do?structureId=1YI4">1YI4</a>
                            </td>
                        </tr>
                        <tr>
                            <td>Staphylococcus Aureus Gyrase B with Inhibitor</td>
                            <td>23.09</td>
                            <td>32.49</td>
                            <td>33.93 / 20th</td>
                            <td> 5.45%</td>
                            <td>94.78%</td>
                            <td> 2.93 / 28th</td>
                            <td>2.3</td>
                            <td>
                                <a href="http://www.rcsb.org/pdb/explore/explore.do?structureId=3G75">3G75</a>
                            </td>
                        </tr>
                        <tr>
                            <td>Janus Kinase Bound to Inhibitor</td>
                            <td>22.07</td>
                            <td>28.60</td>
                            <td>18.87 / 54th</td>
                            <td> 5.75%</td>
                            <td>96.80%</td>
                            <td> 2.55 / 47th</td>
                            <td>2.2</td>
                            <td>
                                <a href="http://www.rcsb.org/pdb/explore/explore.do?structureId=3KCK">3KCK</a>
                            </td>
                        </tr>
                        <tr>
                            <td>Extracellular Signal-Regulated Kinase (ERK2) with Inhibitor</td>
                            <td>20.60</td>
                            <td>24.54</td>
                            <td>11.41 / 94th</td>
                            <td> 3.65%</td>
                            <td>97.26%</td>
                            <td>2.14 / 92nd</td>
                            <td>2.5</td>
                            <td>
                                <a href="http://www.rcsb.org/pdb/explore/explore.do?structureId=3I60">3I60</a>
                            </td>
                        </tr>
                        <tr>
                            <td>
                                <font color="blue">Ewald Refinements</font>
                            </td>
                        </tr>
                        <tr>
                            <td>PIM-1 Bound to Adenosine</td>
                            <td>17.76</td>
                            <td>22.37</td>
                            <td> 3.42 / 99th</td>
                            <td> 7.08%</td>
                            <td>95.85%</td>
                            <td> 2.07 / 91rst</td>
                            <td>2.4</td>
                            <td>
                                <a href="structures/3YI4_Ewald.pdb">1YI4_Ewald.pdb</a>
                            </td>
                        </tr>
                        <tr>
                            <td>Staphylococcus Aureus Gyrase B with Inhibitor</td>
                            <td>20.64</td>
                            <td>30.48</td>
                            <td> 3.74 / 99th</td>
                            <td> 5.13%</td>
                            <td>93.68%</td>
                            <td> 2.12 / 85th</td>
                            <td>2.3</td>
                            <td>
                                <a href="sructures/3G75_Ewald.pdb">3G75_Ewald.pdb</a>
                            </td>
                        </tr>
                        <tr>
                            <td>Janus Kinase Bound to Inhibitor</td>
                            <td>20.83</td>
                            <td>28.13</td>
                            <td>1.67 / 99th</td>
                            <td> 4.56%</td>
                            <td>97.17%</td>
                            <td>1.57 / 93rd</td>
                            <td>2.2</td>
                            <td>
                                <a href="structures/3KCK_Ewald.pdb">3KCK_Ewald.pdb</a>
                            </td>
                        </tr>
                        <tr>
                            <td>Extracellular Signal-Regulated Kinase (ERK2) with Inhibitor</td>
                            <td>18.55</td>
                            <td>26.66</td>
                            <td>3.41 / 99th</td>
                            <td> 4.32%</td>
                            <td>96.96%</td>
                            <td>1.79 / 98th</td>
                            <td>2.5</td>
                            <td>
                                <a href="structures/3I60_Ewald.pdb">3I60_Ewald.pdb</a>
                            </td>
                        </tr>
                    </tbody>
                </table>
            </subsection>
        </section>
    </body>
</document>
